Both insulin aspart and insulin lispro, rapid-acting insulin analogs, control postprandial blood glucose in type 1 diabetic patients, according to a report in the November issue of Diabetes Care. Dr. Johannes Plank, of Karl-Franzens University, Graz, Austria, and colleagues compared the pharmacokinetic and pharmacodynamic profiles of insulin aspart and insulin lispro in type 1 diabetic subjects.
In addition, they examined whether one analog results in favorable effects on prandial blood glucose control.
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!